New psychoactive substances (NPS)
Europe’s ability to rapidly respond to public health and social threats caused by new psychoactive substances (NPS) was significantly strengthened last year thanks to new legislation applicable across Europe. This legislation strengthened the EU Early Warning System (EWS) and risk assessment procedures on NPS and shortened control processes. This month, the EMCDDA has published new operating guidelines for the EWS, addressing measures introduced by the new legislation. The guidelines, which replace those published in 2007, detail the rationale, steps, procedures, roles and responsibilities for operating the system.